KPC Pharmaceuticals (SHSE:600422) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600422 KPC Pharmaceuticals Inc SHSE:600422
68 GF Score
Price ¥9.06
GF Value ¥12.09
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is KPC Pharmaceuticals FFO per Share?

FFO per Share only applies to REITs.

SHSE:600422
68GF Score
KPC Pharmaceuticals Inc SHSE:600422
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is KPC Pharmaceuticals (SHSE:600422) Overvalued in 2026?

Based on GuruFocus' analysis, KPC Pharmaceuticals stock appears to be undervalued. The current stock price of ¥9.06 is trading 25.1% below its estimated GF Value™ of ¥12.09. GuruFocus considers KPC Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for SHSE:600422:

  • FFO per Share:
  • GF Value™: ¥12.09 vs. price of ¥9.06 (25.1% below fair value)
  • GF Score™: 68/100 with 7 warning signs

No single metric tells the full story. See the SHSE:600422 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


KPC Pharmaceuticals Business Description

Address No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
68GF Score

Get the complete analysis for SHSE:600422

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.06
Price
¥12.09
GF Value